title: Topical 0.5% timolol heals a recalcitrant irradiated surgical scalp wound.
authors.affiliation: David Geffen School of Medicine University of California, Los Angeles Los Angeles, California Department of Medicine (Dermatology) David Geffen School of Medicine University of California, Los Angeles Los Angeles, California Department of Dermatology University of California, Irvine Irvine, California Private Practice Newport Beach, California.
authors.forename: Kourosh
authors.initials: K
authors.lastname: Beroukhim
authors.forename: Adam M
authors.initials: AM
authors.lastname: Rotunda
mesh_terms: D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000601:surgery*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D006801:Humans; D008297:Male; D015580:Mohs Surgery; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy / Q000601:surgery*; D018714:Radiotherapy, Adjuvant; D012535:Scalp / Q000601:surgery*; D012878:Skin Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D000319:Adrenergic beta-Antagonists; D013999:Timolol